Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Active, not recruiting Not applicable

A Study to Evaluate the Effects of a Beef Liver Supplement on Energy, Mood, and Mental Clarity

NCT07892911 · tracked via the Priya Life Science USA tracker
Sponsor
Ancestral Supplements, LLC
Phase
Not applicable
Started
2026-09-01
Last updated
2026-10-23

Condition(s) studied

FatigueLow MoodMental ClarityIron DeficiencyBrain Fog

Investigational drug(s) / intervention(s)

InterventionPlacebo

Intervention: Participants receive the Ancestral Supplements Grass Fed Beef Liver supplement (Grass Fed Liver \[Bovine\], 3000 mg per serving of 6 capsules) taken once daily, with a graduated dose escalation from 1 capsule/day over the first 18 days up to the full serving of 6 capsules/day, for 12 weeks.

Placebo: Participants receive a matched placebo product (microcrystalline cellulose and natural food color) taken once daily using the same dosing regimen as the intervention arm, for 12 weeks. The taste and appearance of the placebo are matched to the test product.

Study summary

This is a randomized, triple-blind, placebo-controlled clinical trial evaluating the effects of the Ancestral Supplements Grass Fed Beef Liver oral supplement on energy, mood, and mental clarity over 12 weeks. One hundred male and female participants aged 18-50 who report concerns regarding energy levels, mood, and mental clarity will be enrolled and randomized equally into an intervention arm (beef liver supplement) or a placebo arm.

Participants will take their assigned product once daily and complete self-reported questionnaires at Baseline, Week 4, Week 8, and Week 12. Blood testing (iron panel) will be conducted at Baseline and Week 12 at a local Quest Diagnostics Clinic. The primary objective is to evaluate the product's effects on energy and mood; the secondary objective is to assess participants' perceptions of the product's effects on energy, mood, and mental clarity, including happiness, anxiety, well-being, brain fog, and concentration.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Be male or female * Be aged 18-50 * Anyone experiencing issues regarding all of the following over the past four weeks: energy levels, mood, and mental clarity * Anyone who is generally healthy - does not live with any uncontrolled chronic disease * Anyone who is willing to maintain their current diet, sleep schedule, and activity level for the duration of the study * Resides in the United States Exclusion Criteria: * Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders * Currently taking iron supplements or being treated for anemia * Anyone currently taking oral contraceptives that contain iron * Anyone currently taking vitamin A supplements, or supplements that contain vitamin A * Anyone with any allergies or sensitivities to any of the study product ingredients * Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period) * Anyone with hemochromatosis * Anyone unwilling to follow the study protocol * Has stopped using hormonal birth control in the past month * Anyone who is vegan and/or does not consume animal products for any reason * Anyone who is considered to be a heavy drinker (i.e. 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men) * Planning on introducing any products or any new forms of prescription medication or supplements that target energy levels, mood, or mental clarity, during the study duration * Currently partaking in another research study or will be partaking in any other research study at any point during this study's duration

Primary outcome measure(s)

  • Change in Iron Status — Baseline and Week 12
    Change in blood iron levels assessed via iron panel blood test (Quest Diagnostics, iron test code 001339)
  • Change in Energy Levels — Baseline, Week 4, Week 8, and Week 12
    Change in self-reported energy levels assessed via self-reported questionnaire
  • Change in Mood — Baseline, Week 4, Week 8, and Week 12
    Change in self-reported mood assessed via self-reported questionnaire

Trial sites (1)

FacilityCityRegionStatus
Citruslabs Las Vegas Nevada
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07892911 on ClinicalTrials.gov ↗ ← All trials in the USA